Phaseline

Targets › SCNA1

SCNA1: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Other; next expected readout Dec 2027.

Open in Phaseline: the race on SCNA1, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Northwestern UniversityTopical EMLA cream
Eutectic mixture of local anesthetics (lidocaine and prilocaine) - blocks sodium channels
SCNA1, SCNB1Phase 4Hair RemovalDec 2027

Conditions

Hair Removal (1)

Modalities

small molecule (1)

Companies

Northwestern University (1)

Related targets

SCNB1 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.